Showing results (101-110 of 183) with videos related to
Sort By:
Pageof 19
Sheng Li Xue Bao : [Acta Physiologica Sinica]|October 22, 2004
[Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia]Yan-Rong Liu, Qian-Min Tao, Jun-Zhu Chen, et al.Frontiers in Immunology|July 25, 2022
Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21)Nan Xu, Kai Sun, Ya-Zhe Wang, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 15, 2013
[Clinical characteristics of splenic marginal zone lymphoma with abnormal complete blood count]Shen-Miao Yang, Qian Jiang, Bin Jiang, et al.Leukemia Research|July 2, 2013
Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?Ya-Zhen Qin, Qian Jiang, Hao Jiang, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 22, 2009
[Relationship of immunophenotypic features with minimal residual disease detection and gene types in 221 cases of acute promyelocytic leukemia]Ya-Zhe Wang, Ya-Zhen Qin, Bin Jiang, et al.DNA and Cell Biology|September 28, 2017
PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple MyelomaLu Yang, Ya-Zhe Wang, Hong-Hu Zhu, et al.Oncotargets and Therapy|August 18, 2020
Both Methylation and Copy Number Variation Participated in the Varied Expression of PRAME in Multiple MyelomaLu Yang, Feng-Ting Dao, Yan Chang, et al.Blood|August 2, 2014
In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratificationYu Wang, De-Pei Wu, Qi-Fa Liu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia]Yan-rong Liu, Le-ping Zhang, Yan Chang, et al.Leukemia Research|March 2, 2016
CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patientsXu-Mian Li, Le-Ping Zhang, Ya-Zhe Wang, et al.Pageof 19